GlassScriptPhysician profile
Salina Scheiner
NPI 1932777885
$3,759.40
in general payments reported to CMS, 2019-2025
42 companies · $751 in 2025
The $751 reported for 2025 was more than what 80% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $162 · 2022: $676 · 2023: $835 · 2024: $1,335 · 2025: $751.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,921.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,921.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $653.05 | 2021-2025 | |
| Lilly USA, LLC | $330.02 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $270.84 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $236.22 | 2022-2025 | |
| Antares Pharma, INC. | $189.53 | 2022-2024 | Xyosted, Nocdurna, Tlando |
| Merck Sharp & Dohme LLC | $178.71 | 2022-2024 | Gardasil 9, Capvaxive, Gardasil |
| Janssen Pharmaceuticals, INC | $176.33 | 2021-2025 | Spravato, Xarelto |
| Glaxosmithkline, LLC. | $148.43 | 2023 | Shingrix, Arexvy, Trelegy Ellipta |
| Ardelyx, INC. | $146.75 | 2023-2024 | Ibsrela |
| Exact Sciences Corporation | $109.86 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Axsome Therapeutics, INC. | $100.00 | 2024-2025 | Auvelity |
| Indivior INC. | $95.55 | 2022-2025 | Sublocade |
| Intra-Sana Laboratories | $94.33 | 2023-2024 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Hologic Sales and Service, LLC | $79.14 | 2022-2025 | Aptima |
| Corcept Therapeutics | $79.07 | 2024-2025 | Korlym |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Renalytix Ai, INC. | $77.63 | 2023-2024 | Kidneyintelx Blood Collection Convenience Kit |
| Pfizer INC. | $74.47 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $68.97 | 2022-2024 | Farxiga |
| Halozyme INC | $66.70 | 2023 | |
| Alkermes, INC. | $61.50 | 2022 | |
| Amgen INC. | $58.97 | 2022-2025 | Otezla, Repatha, Repatha |
| Medtronic, INC. | $47.96 | 2024 | Ligasure, Closurefast |
| Allergan, INC. | $46.61 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $37.03 | 2024-2025 | Rexulti |
| Tolmar, INC. | $31.32 | 2024-2025 | Jatenzo |
| Gilead Sciences, INC. | $27.75 | 2021 | |
| Verity Pharmaceuticals INC. | $25.47 | 2024 | Tlando |
| Eisai INC. | $22.60 | 2025 | |
| Clarus Therapeutics INC. | $20.42 | 2021 | |
| Amneal Pharmaceuticals LLC | $19.81 | 2024 | Unithroid |
| Resmed Corp | $18.99 | 2024 | |
| Phathom Pharmaceuticals, INC. | $18.48 | 2024 | Voquezna |
| Amarin Pharma, INC. | $17.74 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.39 | 2023 | Gattex |
| Xeris Pharmaceuticals, INC. | $15.54 | 2024 | Gvoke Hypopen |
| Corium, LLC | $14.60 | 2023 | Azstarys |
| Shield Therapeutics INC | $14.28 | 2023 | Accrufer |
| Inspire Medical Systems, INC. | $14.24 | 2025 | Inspire |
| Supernus Pharmaceuticals, INC. | $14.17 | 2023 | Xyosted, Qelbree |
| Medicomp INC | $13.62 | 2022 | |
| Evoke Pharma, INC. | $13.16 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Salina Scheiner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.